Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.72935 | 62 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.55328 | 59 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.64859 | 61 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.52224 | 59 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.56401 | 60 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.87378 | 64 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 4.17109 | 68 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.61471 | 60 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.62926 | 61 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.60201 | 60 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.63103 | 61 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.53775 | 60 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.70524 | 62 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.63689 | 61 |